Reducing Opiate and Benzodiazepine Exposure in Preterm Infants on High-Frequency Jet Ventilation

Area of Science:

• Neonatal Intensive Care
• Quality Improvement Science
• Pharmacology

Background:

• Extremely low birth weight (ELBW) newborns face heightened risks of pain and agitation.
• Standard treatments involve opiates and benzodiazepines, linked to adverse neurodevelopmental and pulmonary outcomes.
• Reducing these medications is crucial for ELBW infant well-being.

Purpose of the Study:

• To decrease opiate and benzodiazepine doses by 50% in ELBW infants on high-frequency jet ventilation.
• To sustain this reduction for at least 6 months.
• To improve patient outcomes in a level IV neonatal intensive care unit.

Main Methods:

• A multidisciplinary team implemented a quality improvement initiative using the Model for Improvement.
• Key drivers identified included medication awareness, standardized pain assessments, and clear medication indications.
• Plan-Do-Study-Act cycles and statistical process control charts analyzed intervention effectiveness.

Main Results:

• Cumulative doses of opiates decreased by 75.9% and benzodiazepines by 61.5%.
• Improvements were observed in guideline adherence and pain documentation.
• Adverse events, including pain scores and unplanned extubations, did not increase.

Conclusions:

• Standardizing medication administration, pain assessments, and audits significantly reduced opiate and benzodiazepine exposure.
• A multidisciplinary quality improvement approach proved effective in minimizing medication risks for ELBW infants.
• The implemented changes were sustained, demonstrating long-term benefits.